Fig. 1.
Id constructs used for the vaccination: (a) Id protein coupled to KLH 50 μg injected subcutaneously twice 2 weeks apart, (b) scFv-muGM-CSF protein 50 μg injected intraperitoneally 3 times 2 weeks apart, (c) Id plasmid DNA (with human IgGκ constant regions) 100 μg injected IM 3 times 1 week apart, and (d) AdV containing the sequence encoding the scFv injected once IM at a dose of 3 × 107 pfu.
